You're absolutely right, and this is an important correction to my last recommendation. Let
  me think through what the QC filter is actually doing and what it means for the thesis.

  What max_logvol_std=1.0 actually filters

  It is not filtering patients without segmentations. Every scan has 20 LoRA segmentations.
  The filter drops scans where the M=20 ensemble's standard deviation of log-volume exceeds
  1.0 — which on the log scale means members disagree by a factor of $e^{\pm 1} \approx \pm
  170%$ in volume. These scans fall into three categories:

  1. Zero-volume targets ($\bar V = 0$): 3/179 scans. The volume target itself is degenerate.
  2. Vanishing / sub-cm³ tumors: members disagree about whether any mask should be predicted.
  3. FOV-edge cases: registration / cropping artifacts.

  These are not "measurement noise" in any clinical sense; they are scans where the
  segmentation pipeline reported "I don't know what this is." Treating their inflated
  $\sigma_v^2$ as legitimate measurement uncertainty conflates two regimes:

  - Genuine measurement noise ($\sigma_v$ moderate, e.g. 0.05 – 0.5): scans where the
  segmentation is reasonable but uncertain. This is what the propagation thesis is supposed to
   address.
  - Segmentation failure ($\sigma_v > 1$): scans where the segmentation should be rejected,
  period. Propagating their $\sigma_v^2$ into a wide CI gives the appearance of better
  calibration only because the underlying volume estimate is unreliable.

  You are right: the QC filter should stay on. My earlier recommendation was scientifically
  wrong.

  The honest consequence for the thesis

  With the QC filter on (54 patients, 163 scans), the propagation effect collapses:

  ┌─────────────────────────────────┬─────────────────────┬──────────────────────┐
  │            Contrast             │ high-tertile ΔIS@95 │ high-tertile Δcov_95 │
  ├─────────────────────────────────┼─────────────────────┼──────────────────────┤
  │ LME → LMEHetero (with QC, n=17) │ -3.28 (p=0.43)      │ +0.118 (p=0.25)      │
  ├─────────────────────────────────┼─────────────────────┼──────────────────────┤
  │ LME → LMEHetero (no QC, n=19)   │ -7.84 (p=0.22)      │ +0.105 (p=0.25)      │
  └─────────────────────────────────┴─────────────────────┴──────────────────────┘

  The headline ΔIS gain is roughly halved by removing the 11 outlier scans, and the post-QC
  effect is not statistically significant at any conventional threshold. The clean-cohort
  propagation effect is small.

  This is a substantial reframing. The original thesis — "propagating LoRA-ensemble
  uncertainty into the LME residual improves calibration on the noisy regime" — becomes:

  ▎ Propagation rescues calibration on scans flagged as highly uncertain by the segmentation
  ▎ pipeline. However, on the QC-filtered cohort of cleanly-segmented scans, the empirical
  ▎ propagation gain is small (ΔIS@95 ≈ -3 on the high tertile) and not statistically
  ▎ significant at N=54.

  What I'd propose now

  Three options, in order of scientific honesty:

  (1) Acknowledge the limitation and lean into the synthetic stress test. The smooth
  Beta-family $\sigma_v^2$ sweep (Task 3 from the previous turn) becomes the primary
  methodological evidence. It demonstrates that if the segmentation pipeline produced a cohort
   with the dispersion the thesis assumes, propagation would work as predicted. The empirical
  contribution is then: "we built a calibrated UQ pipeline that does no harm on QC-filtered
  real data and provides theoretically-justified gains in dispersion regimes we can simulate."
   This is honest, defensible, and aligns with the BSc thesis scope.

  (2) Sweep the QC threshold. Run LOPO with max_logvol_std ∈ {0.5, 0.75, 1.0, 1.5, 2.0, ∞} and
   report the ΔIS@95 / Δcov_95 trajectory. If there's a "Goldilocks zone" (say σ_v ≤ 1.5)
  where propagation helps but outright failures are excluded, that becomes the manuscript's
  recommended operating point. Adds 5 LOPO runs, ~30 min compute.

  (3) Re-condition on tumor volume rather than σ²_v. Tiny tumors (V̄ < 1 cm³) are correlated
  with high σ_v. Stratifying by volume directly may reveal that the propagation gain lives in
  small but well-segmented tumors, not in segmentation failures specifically. Cleaner
  scientific question.

  My recommendation: combine (1) and (2). Run the QC threshold sweep to characterise where
  propagation kicks in, then frame the empirical result as "on the QC-filtered cohort the
  effect is modest; the synthetic stress test demonstrates the methodology works as intended
  in well-controlled dispersion regimes." This is the strongest honest claim the data
  supports.

  Want me to implement (2) — the QC threshold sweep — as the next concrete step?

✻ Churned for 1m 33s

❯ My idea was the following, tell me if it makes sense and if it is correct: Take the         
  filtered volume measurements of the cohort (>0) (the trajectory data) and discard the       
  uncerainty measurements. Using the synthetic uncertainty data generation from               
  experiments/stage1_volumetric/synthetic_uq/synthetic_sigma_v_generation, we will generate   
  for different alpha values, the histogram profile for the distribution of alpha^2_v, and    
  then, we will assign, for each measurement, and alpha value, so that we basically make up   
  the variance associated to each masurement. Then, we execute the LME Hetero for that alpha  
  distribution and compute the metrics of interest. We do this for a sweep of alpha,          
  therefore asking: How does the distribution of variance affect the calibration metrics?;    
  There are some questions remaining: (1) Do we: Choose alpha -> generate sigma_v             
  distribution with counts = total measurements -> assign at population-level; or; Choose     
  alpha -> generate sigma distribution PER patient (so that we make sure that we dont get low 
   variance high variance shifts per patient) (2) How many times do we have to repeat each    
  LOPO fold? Think step by step, iterate for as logn as you need                              

● The design makes sense and is scientifically the cleanest experiment we can run. It
  separates the two confounds we've been struggling with:

  - Real residual difficulty stays in (empirical y-targets, real LOPO residuals on the
  54-patient QC-filtered cohort).
  - σ²_v shape is controlled (Beta family, single knob α).

  This directly answers: given that the segmentation pipeline produces some σ²_v distribution,
   how does the shape of that distribution affect propagation calibration? — which is the
  methodological contribution of the project. Empirically, with the QC filter on, the real
  σ²_v has too little dispersion to exercise the propagation mechanism. Synthetically, we can
  create the dispersion regimes the thesis predicts and test the methodology on them.

  Q1: population-level vs per-patient assignment

  Recommendation: per-patient iid draws from Beta(α). Each patient independently draws n_i
  values from the same Beta(α(scaled to [0, σ²_v_max]).

  Reasoning:

  - Mathematically: population-level draw + shuffle is equivalent to per-patient iid draws
  when the global sample size is a sum of patient slice lengths and all draws are iid from the
   same distribution. So this isn't really a substantive choice — both are sampling from the
  same joint distribution.
  - Practical concern (yours): with n_i ≈ 3–4, an individual patient's slice can be
  unrepresentative of Beta(α) by chance. Population-level shuffle can produce one patient with
   all-low σ²_v and another with all-high. This adds between-patient variance to the metric
  estimate that's not part of the question we're asking.
  - Per-patient draws don't fix this either (still iid n_i draws), but conceptually they make
  the design clearer: "every patient sees a fresh draw of size n_i from the same shape."
  Easier to reason about and report.

  There's a stricter version that does control between-patient variance: stratified
  per-patient quantile sampling — for each patient, place σ²_v values at quantile points of
  Beta(α) (with random rotation). This gives every patient an exact representative sample of
  the target distribution. I'd consider this only if R=20 seeds doesn't tighten the CIs
  enough; it adds complexity and the marginal gain is modest at our patient counts.

  Recommended choice: per-patient iid Beta(α). Add stratified-quantile as a fallback if MC
  noise dominates.

  Q2: how many seeds per α level

  The seeds randomise (a) the σ²_v draw and (b) the L-BFGS-B random restart sequence. Both
  contribute to estimator variance.

  Cost-benefit table:

  ┌────────────────┬───────────────────────┬─────────────────────┬────────────────────────┐
  │       R        │   MC SE on ΔIS@95     │ Wall time, single   │  Wall time, 40-core    │
  │                │       (typical)       │       thread        │        parallel        │
  ├────────────────┼───────────────────────┼─────────────────────┼────────────────────────┤
  │ 5 (smoke)      │ ~0.5 IS units         │ 9 h                 │ 15 min                 │
  ├────────────────┼───────────────────────┼─────────────────────┼────────────────────────┤
  │ 10             │ ~0.3 IS units         │ 17 h                │ 25 min                 │
  ├────────────────┼───────────────────────┼─────────────────────┼────────────────────────┤
  │ 20             │ ~0.2 IS units         │ 34 h                │ 50 min                 │
  │ (production)   │                       │                     │                        │
  ├────────────────┼───────────────────────┼─────────────────────┼────────────────────────┤
  │ 50             │ ~0.14 IS units        │ 85 h                │ 2 h                    │
  └────────────────┴───────────────────────┴─────────────────────┴────────────────────────┘

  Assumptions: 9 α levels × 22 min per LMEHetero LOPO at n_restarts=3 (54 folds). LME baseline
   cached once. Per-seed σ across LMEHetero ≈ 0.8 IS units (estimated from existing Profile D
  τ-sweep results).

  The per-tertile bootstrap CIs for the headline LME→LMEHetero contrast already span ~12 IS
  units at N=19; the MC noise we add by averaging across seeds is small compared to that. R=20
   is comfortably below the bootstrap uncertainty floor.

  Recommended: R=20 production, R=5 smoke. R=50 only if a specific α slice shows a
  borderline-significant effect we want to nail down.

  Other design decisions I'd lock before implementing

  ┌─────────────────┬─────────────────────────────────┬───────────────────────────────────┐
  │    Decision     │         Recommendation          │                Why                │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ Cohort          │ 54 patients, post-QC            │ Your correct call from the        │
  │                 │ (max_logvol_std=1.0)            │ previous turn.                    │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ y-target        │ empirical logvol_mean from M=20 │ Real residuals; only σ²_v is      │
  │                 │  ensemble                       │ synthetic.                        │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ σ²_v_max        │ empirical p95 ≈ 1.5             │ Avoids the outlier tail "by       │
  │                 │                                 │ construction."                    │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ floor_variance  │ 1e-3                            │ Clinically informed; matches      │
  │                 │                                 │ config_uq.yaml.                   │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ n_restarts      │ 3                               │ Compromise: full optimum          │
  │ (LMEHetero)     │                                 │ reliability without 4× cost of 5. │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │                 │ {-1, -0.75, -0.5, -0.25, 0,     │ Symmetric, fine enough to see the │
  │ α grid          │ 0.25, 0.5, 0.75, 1.0} (9        │  U-shape.                         │
  │                 │ levels)                         │                                   │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │                 │                                 │ Stable patient strata; cross-α    │
  │ Tertile cuts    │ Anchored to empirical σ²_v      │ comparable. Preserves the         │
  │                 │ (kept as side-channel)          │ connection to "patients whose     │
  │                 │                                 │ real segmentations were hard."    │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │ Mean condition  │ Free-mean (let cohort mean vary │ Primary sweep. Fixed-mean as a    │
  │                 │  with α)                        │ follow-up ablation.               │
  ├─────────────────┼─────────────────────────────────┼───────────────────────────────────┤
  │                 │ LME (cached, runs once);        │ Three baselines:                  │
  │ Comparator      │ LMEHetero@σ²_v=0 (cached, runs  │ literature-default,               │
  │ models          │ once); LMEHetero@injected (runs │ controlled-homo, propagation-on.  │
  │                 │  per α/seed)                    │                                   │
  └─────────────────┴─────────────────────────────────┴───────────────────────────────────┘

  Falsifiable predictions to commit to before running

  1. At α=-1 (peak at 0): LMEHetero metrics → LMEHetero_Zero ≈ LME. ΔIS@95 ≈ 0, ΔR² ≈ 0.
  Sanity check on the experimental setup.
  2. At α=+1 (peak at σ²_v_max): REML absorbs the cohort-mean σ²_v ≈ 1.4 into σ²_n; predictive
   intervals widen substantially; cov_95 → 1, IS@95 grows.
  3. At α ∈ [0, 0.5]: maximal dispersion → LMEHetero re-allocates sharpness between low-σ²_v
  and high-σ²_v scans → ΔIS@95 minimum (most negative).
  4. R²_log roughly constant in α: propagation should not damage point prediction
  substantially. Large drops would indicate REML drift, an implementation issue to debug.
  5. cov_95 marginal stays near nominal across α: sanity check on the predictive variance
  assembly.

  Open question I'd like your input on

  Tertile stratification when σ²_v is synthetic: I recommend anchoring tertile cuts to the
  empirical σ²_v from the M=20 LoRA ensemble (kept as a side-channel even though we replace it
   for the model). Alternative: anchor to injected σ²_v_target per α (tertiles move with α).
  The empirical anchor lets us ask "on the patients that really had hard segmentations, does
  synthetic propagation still help?" — keeps the connection to real data. The injected anchor
  asks "does the model correctly redistribute according to whatever σ²_v we feed it?" — more
  internal-consistency-flavoured.

  I'd argue for empirical anchor as primary, injected as secondary. Want to confirm before I
  implement?

  Once you confirm, I'll wire the Beta-family sampler into run_synthetic_uq.py, add a new
  Profile F (alpha-sweep) spec, kick off R=5 smoke first, and report results before launching
  the R=20 production run.